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Abstract We compared sexual behaviors/partnerships and
determined sexual risk correlates associated with HIV by
gender among street-recruited drug users using chi-square
tests and logistic regression. Men reported higher risk sexual
behaviors, yet fewer high-risk sexual partners than women.
After adjustment, HIV seropositive men were more likely
than seronegatives to be older, MSM, use condoms, and
have an HIV-infected partner. HIV seropositive women were
more likely to be older, have an HIV-infected partner, and not
use non-injected heroin. IDU was not associated with HIV.
Prospective studies are needed to determine how gender-
specific sexual behaviors/partnerships among drug users af-
fect HIV acquisition.
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Introduction
Recent reports have indicated that HIV prevalence and inci-
dence is decreasing among injection drug users (IDUs; Des
Jarlais et al., 2000). HIV prevalence among IDUs in the late
1990’s ranged from 2 to 10% (Fuller et al., 2003) and in-
cidence has been estimated at 0–1 per 100 person-years in
most published reports (Des Jarlais et al., 2000). Preven-
tion efforts focused on reducing high-risk injection practices
among IDUs have likely contributed to the decline of HIV
among IDUs in the US (Semaan et al., 2002). Less dramatic
declines have been noted among non-IDUs in whom HIV
prevalence rates have been estimated up to 15% in published
studies in the US and abroad (Chitwood, Comerford, and
Sanchez, 2003). These high rates of HIV among injecting
and non-injecting drug users suggest that high-risk sexual
behaviors may be of increasing importance in HIV transmis-
sion in these populations.
Prior studies that have evaluated sexual risk behaviors in
drug users have been largely among IDUs (Latkin, Mandell,
and Vlahov, 1996). Of the reports that assessed sexual risk
behaviors among non-IDUs, a clear association for sexually
transmitted HIV has been demonstrated in crack users (Edlin
et al., 1994). Few studies have been conducted on the sex-
ual risk behaviors of IDUs in the context of the currently
declining rates of HIV, during a period of decreased crack
use (Department of Health and Human Services, 2003) or
among a more diverse sample of non-IDUs such as those
who use non-injection heroin, intranasal, or inhaled cocaine.
In addition, while prior studies have identified gender-based
differences in sexual behaviors in various populations, recent
evidence among HIV-infected drug users have highlighted
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the need to further explore issues on the influence of sex-
ual partner type including HIV serostatus of sexual partners
(Semple, Patterson, and Grant, 2002).
To characterize the association of sexual behaviors and
sexual partner type with HIV seropositivity among male and
female drug users, we conducted a cross-sectional analysis of
baseline data collected among IDUs and non-IDUs enrolled
in two prospective cohort studies in New York City (NYC).
The objectives of this analysis were to describe gender differ-
ences in sexual behaviors, and identify sexual behaviors and




Study participants were recruited using street outreach tech-
niques into two ongoing studies from communities with high
rates of illicit drug use. Research staff familiar with places
in the community where drugs were bought or used, en-
gaged potential participants in conversations about ongoing
research conducted by the Center for Urban Epidemiologic
Studies (CUES) at the New York Academy of Medicine.
Those interested in participation were screened for eligibility
at one of two community-based storefronts or the CUES re-
search study van for enrollment into the HOPE cohort study,
targeting non-IDUs, or the Hepatitis C cohort study, targeting
newly initiated IDUs. HOPE study participants were eligible
if they were between 15 and 40 years of age, reported non-
injection use of heroin, crack or cocaine at least one time per
week, but for no longer than 10 years, and had no history of
injecting drugs. Eligibility for the Hepatitis C study included
age 15–40 years and reported injection of heroin or cocaine
at least once in the last 2 months but for no longer than 5
years.
Measures
Participants in each study were interviewed in a private room
using a standardized drug and sexual risk survey. The sur-
vey included questions about sociodemographics, drug type
and frequency of use, drug route of administration, drug-
using companions, and sexual behaviors. Sociodemographic
variables collected included: Age, race/ethnicity, education
level, nationality, homelessness, and prior incarceration. We
assessed whether participants used crack, cocaine, heroin,
metamphetamines, hallucinogens, marijuana, or tranquiliz-
ers and asked whether they injected, snorted, sniffed, or
smoked each of these drugs. We collected information on
sexual behaviors including age of sexual debut, drug use be-
fore, during, and after sexual acts, condom use, as well as
gender and type of sexual partners. Sexual partner type was
categorized as a steady, casual, or exchange-for-sex partner.
A steady partner was defined as a person to whom par-
ticipants felt strong emotional closeness; a casual partner
was one with whom they were not emotionally close and
an exchange-for-sex partner was a person with whom they
traded sex for money or drugs. Participants were also inter-
viewed about the HIV status and drug-using behaviors of
each type of sexual partner.
Following each interview, participants received HIV pre-
test counseling and had blood drawn for serologic testing.
Post-test counseling was provided 3 weeks later when par-
ticipants returned for HIV results. Referrals for social and
medical services were provided as appropriate during that
time. HIV antibodies were detected using enzyme-linked im-
munosorbant assay (ELISA) for HIV types 1 and 2 (Abbott
Laboratories, Abbott Park, IL) with a confirmatory West-
ern Blot for HIV type 1 (Calypte Biomedical Corporation,
Alameda, CA).
Data analyses
Baseline data from the Hepatitis C and HOPE studies were
combined for this analysis and restricted to those who re-
ported any oral, anal, or vaginal sex within the past 2 months.
All analyses were stratified by gender. Sexual behavior and
sexual partner variables were further evaluated by same-
gender sexual behavior. Men were defined as heterosexual,
men who have sex only with men (exclusive MSM) or men
who reported sex with men and women (MSM/W). Women
were categorized as heterosexual, women who reported sex
only with women (exclusive WSW) or women who report
sex with men and women (WSW/M).
Gender stratified bivariate analyses were conducted to ex-
amine sociodemographic, drug use, sexual risk behavior, and
sexual partner variables using chi-square or Fisher’s exact
tests for categorical variables and t-tests for continuous vari-
ables. Significant bivariate associations between exposure
variables of interest and HIV seropositivity using p-values
<.10 were used to help guide model building. Plausible inter-
actions between gender and drug-using and sexual behavior
variables were also explored using a p-value <.20 to help
guide selection of variables for inclusion in the final model.
Two separate final models using logistic regression were de-
veloped for men and women to determine the independent
effect of each variable of interest as it related to HIV seropos-
itivity.
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Results
Gender differences in sociodemographic and drug-use
characteristics
One thousand and four participants were enrolled and in-
terviewed between August 2000 and November 2003. Of
these, 818 were sexually active within the prior 2 months
and were included in this analysis. Table 1 provides de-
tails of participant demographic characteristics and drug-use
type by gender. Men were younger (mean age 28 years ver-
sus 30 years, p < .01), more often Latino (63% versus 41%;
p < .01), and more likely to report recent homelessness (61%
versus 50%; p < .01) or prior incarceration (90% versus 79%;
p < .01) compared to women. More men than women were
IDUs (29% versus 20%; p < .01). Among non-IDUs, men
were less likely to report crack use compared to women
(56% versus 55%, p < .01) and more likely than women to
use marijuana (77% versus 68%, p < .05) or hallucinogens
(20% versus 9%, p < .01). Intranasal cocaine and heroin use
was similar between groups.
Gender differences in reported sexual behaviors and
sexual partner characteristics
Reported sexual behaviors and characteristics of sexual part-
ners within the preceding 2 months of study enrollment are
detailed in Table 2. The majority of participants were hetero-
sexual; however, 11% of men and 20% of women reported
same gendered sex. Five percent of men (50% of MSM)
and 13% of women (65% of WSW) reported sex with both
men and women (data not shown). Approximately 29% of
women reported a male partner who was an MSM (data not
shown). Though most participants reported that they had a
steady sexual partner, fewer men than women (74% versus
88%; p < .01) reported a steady partner. Men more often
than women reported having a casual sexual partner (52%
versus 31%; p < .01), multiple sexual partners (54% versus
34%; p < .01), and being high during sex (84% versus 76%;
p < .05). There were no gender differences with respect to
having sex in exchange for money or drugs. Condom use
overall was low for both men and women (34%) and did not
differ by gender or by type of sexual partner.
Among participants who reported having a steady sexual
partner, men were less likely than women to have a drug-
using steady partner (9% versus 23%, p < .01, for IDU steady
partner; 37% versus 70% p < .01, for non-IDU steady part-
ner). Among participants who reported an exchange-for-sex
partner, men more frequently than women reported a non-
IDU partner (85% versus 67%, p < .01). Men and women
reported similar rates of known HIV-infected sexual part-
ners, irrespective of partner type.
HIV serostatus
Overall, HIV seropositivity was 9% and significantly lower
among men than women (7% versus 13%, p < .05) (Ta-
ble 2). This trend was similar when we compared HIV rates
in heterosexual men (5%) to those in heterosexual women
(12%, p < .01), and while MSM (24%) had higher rates
of HIV than WSW (17%) the difference was not statis-
tically significant. Further analysis of HIV rates by sex-
ual orientation (data not shown) revealed that exclusive
MSM had the highest rates of HIV (41%) compared to
MSM/W (9%) or heterosexual men (5%, p < .01, Fisher’s ex-
act test). Rates of HIV among women were somewhat higher
among WSW/M (20%) compared to rates in exclusive WSW
(13%) or heterosexual women (12%, p>.05, Fisher’s exact
test).
Characteristics associated with HIV seropositivity
We explored demographic, sexual behavior, sexual part-
nership and drug use characteristics associated with HIV
seropositive status stratified by gender on bivariate and mul-
tivariable analysis (Table 3). On bivariate analysis, HIV
seropositive men were more likely to be older, of black race,
and be better educated, while men who were recently home-
less were less likely to be HIV seropositive than seronega-
tives. Sexual behavior and partner characteristics associated
with HIV seropositivity in men included being an MSM,
having an HIV-infected steady or casual/exchange-for-sex
partner, having a non-IDU steady sexual partner, and using
a condom with steady sexual partners at least 50% of the
time. No association was found between HIV seropositivity
and condom use with casual or exchange-for-sex partners in
men.
After adjustment for age and recent homelessness, be-
ing an MSM (AOR = 5.59), having an HIV-infected steady
(AOR = 7.22), or non-steady partner (AOR = 15.36), and us-
ing condoms consistently with steady partners (AOR = 3.65)
were significantly associated with being HIV seropositive
compared with being seronegative among men.
Among women, on bivariate analysis (Table 3), increasing
age and black race were characteristics associated with being
HIV seropositive. Women with multiple sexual partners, an
HIV-infected steady, or non-steady partner and who reported
consistent condom use with steady partners were more likely
to be HIV seropositive than seronegative. Intranasal heroin
use was associated with a lower likelihood of being HIV
seropositive among non-IDU women compared to non-IDUs
who did not use heroin.
After adjustment for age, HIV seropositive women were
less likely to report intranasal heroin use (AOR = 0.35)
and more likely to have an HIV-infected steady sexual
partner (AOR = 9.39), or non-steady partner (AOR = 6.41)
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Table 1 Comparison of demographic characteristics and drug types used in male versus female drug users, New York City
2000–2003
Men (N = 590) Women (N = 228)
N % N % dfa χ2b
Mean age in years (SD) 28 (6.25) 30 (6.61) 816 − 4.32c,∗
Race/ethnicity
Latino 371 63 91 41 3 48.38∗
Blackd 183 31 98 44
White 15 3 26 12
Other 21 7 9 4
Completed less than high school
Yes 323 55 134 59 2 4.06
No 265 45 84 41
Homeless in preceding 6 months
Yes 357 61 115 50 1 6.97∗
No 232 39 113 50
Ever arrested
Yes 527 90 180 79 1 15.63∗
No 62 10 48 21
Injection drug user (ever)
Yes 173 29 46 20 1 7.02∗
No 417 71 182 80
Non-injection drug user (last 6 months, N = 812)
Crack
Yes 326 56 150 66 1 7.23∗
No 259 44 77 34
Sniff/snorts cocaine
Yes 407 69 146 64 1 2.08
No 178 30 81 36
Smokes/snorts heroin
Yes 337 58 121 47 1 1.23
No 248 42 106 53
Tranquilizers
Yes 149 26 160 71 1 1.37
No 436 74 67 29
Marijuana
Yes 448 77 155 69 1 5.89∗∗
No 137 23 72 31
Snort/smokes methamphetamine
Yes 13 2 1 99 – –e
No 572 98 226 1
Hallucinogens
Yes 117 20 20 9 1 14.60∗




dBlack race/ethnicity includes self-identified African American, black Caribbean, and African participants.
eFisher’s exact test was used, which does not have a formal test statistic.
∗p < .01. ∗∗p < .05.
compared with HIV seronegative women. Injection drug use
was not associated with HIV seropositivity among men or
women and was not further considered in the multivariate
analysis.
Discussion
Among this sample of illicit drug users, we identified promi-
nent gender differences with respect to sexual behaviors
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Table 2 Comparison of differences in sexual behaviors, sexual partner characteristics and HIV seropositivity of
male vs. female drug users, New York City 2000–2003
Participant sexual behaviorsa N = 818
Men (N = 590) Women (N = 228)
N % N % dfb χ2c
Sexuality
Heterosexual
Yes 523 89 182 80 1 10.74∗
MSM or WSWd
Yes 67 11 46 20
Currently lives with sexual partner
Yes 211 36 135 59 1 37.04∗
No 379 64 93 41
Reports a steady sexual partner
Yes 437 74 201 88 1 18.45∗
No 151 26 27 12
Reports a casual sexual partner
Yes 304 52 70 31 1 28.19∗
No 280 48 154 69
Reports an exchange-for-sex partner
Yes 158 27 71 31 1 1.55
No 432 73 157 69
Multiple sexual partnerse
Yes 317 54 78 34 1 25.09∗
No 273 46 150 66
Often high during sexf
Yes 487 84 173 76 1 0.01∗∗
No 95 16 55 24
Condom use with sexual partners
0 to < 25% of the time 283 48 121 53 3 2.47
25 to <50% of the time 36 6 15 7
50 to <75% of the time 58 10 22 10
75–100% of the time 212 36 69 30
Characteristics of sexual partners
Steady sexual partnersg
Steady partner was ever IDUh
Yes 39 9 45 23 1 22.90∗∗
No 391 91 149 77
Steady partner is a non-IDUh
Yes 157 37 138 70 1 60.64∗∗
No 272 63 59 30
HIV-infected steady sexual partner
Yes 21 5 12 6 1 0.38
No 416 95 189 94
Casual sex partnersi
Casual partner was ever IDUh
Yes 33 12 3 5 1 2.61
No 238 88 57 95
Casual sex partner is a non-IDUh
Yes 162 56 37 58 1 0.18
No 125 44 27 42
HIV-infected casual sexual partnerj
Yes 8 3 3 6 – –
No 242 97 50 94
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Table 2 Continued
Characteristics of sexual partners N = 818
Men (N = 590) Women (N = 228) dfb χ2c
N % N %
Exchange-for-sex Partnersk
Exchange-for-sex partner ever IDUh
Yes 29 22 9 17 1 0.56
No 101 78 43 83
Exchange-for-sex partner a non-IDUh
Yes 123 85 42 67 1 9.53
No 21 15 21 33
HIV-infected exchange-for-sex partnerj
Yes 6 5 3 6 – –
No 110 95 46 94
HIV seropositivity
Overall
Yes 43 7 29 13 1 6.04∗
Heterosexuall
Yes 27 5 21 12 1 8.65∗∗
MSM (N = 67) or WSW (N = 46)
Yes 16 24 8 17 1 0.69
aBehaviors are within the prior 2 months unless otherwise stated. Not all respondents answered all the questions.
bDegree of freedom.
cχ2: Chi-square statistic.
dMSM (men who report sex with a man); WSW (women who report sex with women).
eMultiple is defined as more than one sexual partner with the preceding 2 months.
f Reports being high at least half of the time or more when having sex.
gAmong those with steady partners total N = 641 (440 men, 201 women).
hInjection drug user.
iAmong those with casual partners N = 377 (307 men, 70 women).
jFisher’s exact test was used, which does not have a formal test statistic.
kAmong those with exchange for sex partners N = 229 (158 men, 71 women).
lN = 705 (523 men, 182 women).
∗p<.01. ∗∗p<.05.
and sexual partner characteristics. HIV seroprevalence in
this group was highest among drug-using MSM. Prevalence
among heterosexual women was nearly double that of het-
erosexual men and rates among WSW were nearly four
times that of heterosexual men. This significantly higher
HIV prevalence in MSM and women compared to hetero-
sexual men did not appear to be attributable to drug-using
risk behaviors, but instead to high-risk sexual behaviors. In
addition, sexual partner characteristics were primary factors
associated with HIV for both men and women. A notable
gender difference identified in this study was the difference
in risk of steady compared to casual partnerships. Specifi-
cally, our data suggest that characteristics of steady partner-
ships contributed to the higher rates of HIV among women,
while characteristics of non-steady partnerships contributed
to rates among men. The differential influence of steady
versus casual partners in men and women should be inter-
preted with caution however and requires further verification
in larger scaled studies.
Men engaged in more high-risk sexual behaviors when
compared to women. Despite this, women had higher rates
of HIV than heterosexual men. One possible explanation
for these findings is that while men engaged in higher per-
sonal sexual risk behaviors, women more often reported sex
with higher risk partners (IDU and non-IDU steady sexual
partners). In addition, recent reports have suggested that the
increasing rates of HIV infection among women may be in
part related to sex with MSM who also have sex with women
and that this group of men may be acting as a “bridge” be-
tween risk groups (Kalichman and Roffman, 1998).
HIV seropositivity rates in WSW were, however, slightly
higher (17% versus 11–12%) than heterosexual women.
A recent analysis conducted among this same study sam-
ple compared heterosexual women with WSW and found
Springer
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Table 3 Final adjusted models of factors associated with HIV seropositivity among male and female drug users, New York City 2000–2003
Parameter ORa 95% CIb dfc χ2d AORe 95% CIb dfc χ2d
Men
Mean age (SD)f 1.10 1.05, 1.16 1 14.04∗ 1.08 1.02, 1.14 1 6.44
Black Raceg 3.8 2.01, 7.20 1 16.78∗∗ – – – –
Homeless in preceding 6 months 0.32 0.16, 0.64 1 8.16∗ 0.29 0.14, 0.62 1 10.08∗∗
Educationh 3.00 1.31, 6.87 1 6.76∗∗ – – – –
MSMi 5.22 2.65, 10.27 1 25.32∗ 5.59 2.50, 12.49 1 17.62∗
HIV-infected steady sexual partnerj 13.43 5.12, 34.26 1 14.92∗ 7.22 1.89, 27.52 1 8.39∗
HIV-infected casual or
exchange-for-sex partnerk
21.20 5.58, 80.46 1 21.45∗ 15.36 3.06, 77.06 1 11.02∗
Condom use with steady sexual partner
25–50% of the timel
4.00 0.79, 20.16 1 2.79∗∗∗ 2.72 0.39, 19.11 1 1.01
Condom use with steady sexual partner
50–75% of the timel
2.69 0.70, 10.33 1 2.19∗∗∗ 4.47 0.96, 20.89 1 3.62
Condom use with steady sexual partner
75–100% of the timel
3.49 1.48, 8.21 1 6.82∗ 3.64 1.50, 8.87 1 8.13∗
Steady sexual partner is a non-IDUm 1.84 0.97, 3.49 1 3.48∗∗∗ – – – –
Injection drug user 0.55 0.25, 1.22 1 2.16 – – – –
Women
Mean age (SD)f 1.11 1.04, 1.19 1 8.77∗ 1.13 1.05, 1.22 1 10.07∗
Black Raceg 8.18 1.05, 63.55 1 4.03∗∗ – – – –
Multiple sexual partnersn 2.72 1.23, 6.00 1 6.15∗∗ – – – –
HIV-infected steady sexual partnerj 8.08 3.43, 40.79 1 9.77∗ 9.39 2.36, 37.37 1 10.10∗
HIV-infected casual or
exchange-for-sex partnerk
3.12 0.52, 18.59 1 4.76∗∗ 6.41 1.11, 37.06 1 4.3∗∗
Condom use with steady sexual partner
25–50% of the timel
5.17 0.86, 31.19 1 3.21∗∗∗ – – – –
Condom use with steady sexual partner
50–75% of the timel
5.17 1.15, 23.33 1 4.56∗∗ – – – –
Condom use with steady sexual partner
75–100% of the timen
2.03 0.86, 4.79 1 2.63∗∗∗ – – – –
Smoked or snorted heroin in the past
6 months
0.33 0.13, 0.80 1 4.42∗ 0.35 0.14, 0.84 1 5.49∗∗
Injection drug user 0.42 0.12,1.44 1 1.92 – – – –
aOdds ratio.




f Age is included as a continuous variable in years and SD: standard deviation.
gBlack race/ethnicity includes self-identified African American, black Caribbean, and African participants.
hEducation; HS education or equivalent and higher compared to less than high school or equivalent.
iMen who have sex with men.
jReports having only one partner (steady) who is HIV-infected.
kPartner with whom money or drugs were exchanged for sex in the preceding 6 months.
lCompared to participants who report condom use 0 to <25% of the time with sex.
mInjection drug user.
nMultiple is defined as more than one sexual partner with the preceding 2 months.
∗p < .01. ∗∗p < .05. ∗∗∗p < .20.
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that WSW were significantly more likely than heterosexual
women to report sexual partnerships with MSM (Ompad,
Fuller, Galea, Del Vecchio, and Vlahov, 2004a). We were
unable to further explore the relationships between WSW,
WSW/M, and MSM because of limited numbers of partic-
ipants in these subgroups. The findings presented in this
and prior studies, however, highlight important implications
for HIV transmission in communities of color. Our find-
ings suggest that WSW and WSW/M may be a “bridging”
population between MSM and heterosexual men. WSW and
WSW/M have become populations of growing interest, in
light of their high rates of risky drug use and sexual behav-
iors. Further study of these vulnerable women is needed to
understand their risk behaviors and to develop appropriate
interventions.
MSM had the highest prevalence of HIV among this group
despite similar degree of condom use, number and charac-
teristics of sexual partners (i.e., multiple sexual partners,
number of casual partners, and HIV-infected partners) as
heterosexual men. While sexual intercourse with other men
confers significantly higher HIV risk than sex with women,
additional factors may have played a role in the significantly
higher rates of HIV among this group of MSM. For exam-
ple, factors such as lack of disclosure and concurrent sex
with women have been recently cited as important mech-
anisms of HIV transmission in women, but there is little
information regarding the effect on HIV rates among MSM.
The majority of MSM in this group were black or Latino.
Black and Latino MSM continue to be at high risk for HIV,
however only a few studies have examined primarily crack,
heroin- and cocaine-using MSM of color with regard to HIV
risk. In some reports, black and Latino MSM have been
shown to be more likely to have concurrent relationships
with women, be less likely to self-identify as “gay” or ho-
mosexual, engage in higher risk sexual behaviors, and be less
likely to disclose their MSM status compared to white MSM
(Solorio, Swendeman, and Rotheram-Borus, 2003). How-
ever, recent studies among drug-using MSM have noted that
HIV seropositive MSM engaged in lower risk sexual behav-
iors (Fuller et al., 2005). We had too few MSM to fully ex-
plore specific risk factors among this group however we did
identify higher sexual risk partnerships associated with HIV
and this issue merits further exploration among drug-using
MSM.
In both men and women, having a HIV-infected sex-
ual partner was independently associated with being HIV
seropositive. This association was true for casual or steady
partners. Follow-up data are needed to determine if this as-
sociation is as a result of high-risk sexual behaviors with
known HIV-infected partners and resultant HIV acquisition
or if HIV-infected drug users purposely “seek out” sexual
partners who are known to be HIV-infected. The association
of higher levels of condom use and HIV in men is consistent
with this latter hypothesis and possibly represents adoption
of safer sexual behaviors in these men. It is important to
note however that overall condom use was quite low for
both men and women, which highlights the need for effec-
tive prevention strategies to promote condom use among this
vulnerable population. Sexual risk reduction efforts among
populations of drug users will also need to address the dif-
fering issues of sexual risk (and perceived risk) among drug
users who are HIV-infected versus those who are uninfected.
The high prevalence of risky sexual behaviors noted among
HIV-infected populations in treatment and care settings have
demonstrated the need for more intense secondary preven-
tion efforts among this population (Absalon, Della Latta,
Wu, and El-Sadr, 2005). These efforts are likely to be even
more challenging among HIV-infected drug users who may
not be receiving ongoing HIV treatment and care.
With regards to drug use, we found no association be-
tween injection drug-use status and HIV seropositivity for
either men or women. An earlier analysis conducted among
this study sample found that HIV seroprevalence was higher
among non-IDUs and injection status was not a significant
correlate of HIV (Ompad et al., 2004b). To our knowledge,
this finding has not been reported in previous studies of il-
licit drug users. The lack of association between injection
drug use and HIV is also consistent with decreasing inci-
dence of HIV among IDUs in the US (Semaan et al., 2002).
These findings suggest that prevention messages targeting
IDUs to reduce high-risk injection practices have been ef-
fective and support the increasing importance of sexual risk
of HIV among IDUs. We also found no association between
crack use and HIV seropositivity among women or men.
This differs from earlier studies, particularly among crack-
using women who have previously shown high rates of HIV
attributed to unsafe sexual behaviors such as trading sex for
drugs or money (Edlin et al., 1994). However, having an HIV-
infected exchange-for-sex or casual partner demonstrated a
strong association with HIV seropositive status highlighting
behavior as opposed to drug type as an important predictor
and better measure of HIV infection.
Our study differs from other published reports in that we
found no association between race and HIV seropositivity.
This may be related to the small sample of white partici-
pants in this study, which may have resulted in insufficient
power to detect an association between race and HIV serosta-
tus. It should be noted that the cross-sectional design of the
study limits our ability to establish temporality between risk
behaviors and HIV. In addition, participant behaviors and
characteristics of partners were self-reported and could not
be verified and may have generated socially desirable re-
sponses. However, previous research has found self-reported
behavior from drug users to be valid and reliable (Anthony
et al., 1991). Finally, we enrolled participants primarily from
two distinct neighborhoods in NYC and these findings may
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not be generalizable to illicit drug users in other geographic
areas. This line of research should therefore be conducted
in other areas of the US to ascertain whether similar trends
exist, particularly in areas with historically high HIV preva-
lence.
This study contributes significantly to the existing body of
science conducted among vulnerable and high-risk popula-
tions. Prior studies that examined gender differences among
drug users have focused on differences in drug-using behav-
iors or sampled small or restricted populations of drug users.
In addition, given previously reported associations between
high-risk sexual network characteristics and HIV seroposi-
tive status among adult IDUs, similar quantitative social net-
work research among remaining and newly identified risk
groups including IDU and non-IDU MSM, MSM/W, and
women of color are necessary.
This study demonstrates the importance of gender differ-
ences in sexual behavior and sexual partner characteristics
among a sample of IDUs and non-IDUs. These findings are
particularly relevant as the risk of HIV in the US appears
to be shifting from primarily drug-using behaviors to sex-
ual behaviors. Additional prospective studies are needed to
determine the specific effect of these differences on HIV
acquisition and transmission.
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